Azuma J - Search Results

1

Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.

Nonen S, Okamoto H, Fujio Y, Takemoto Y, Yoshiyama M, Hamaguchi T, Matsui Y, Yoshikawa J, Kitabatake A, Azuma J. Nonen S, et al. Among authors: azuma j. Pharmacogenomics J. 2008 Feb;8(1):78-84. doi: 10.1038/sj.tpj.6500450. Epub 2007 Apr 3. Pharmacogenomics J. 2008. PMID: 17404580

2

No positive association between adrenergic receptor variants of alpha2cDel322-325, beta1Ser49, beta1Arg389 and the risk for heart failure in the Japanese population.

Nonen S, Okamoto H, Akino M, Matsui Y, Fujio Y, Yoshiyama M, Takemoto Y, Yoshikawa J, Azuma J, Kitabatake A. Nonen S, et al. Among authors: azuma j. Br J Clin Pharmacol. 2005 Oct;60(4):414-7. doi: 10.1111/j.1365-2125.2005.02447.x. Br J Clin Pharmacol. 2005. PMID: 16187973 Free PMC article.

3

Chronic heart failure: beta-blockers and pharmacogenetics.

Azuma J, Nonen S. Azuma J, et al. Eur J Clin Pharmacol. 2009 Jan;65(1):3-17. doi: 10.1007/s00228-008-0566-7. Epub 2008 Oct 7. Eur J Clin Pharmacol. 2009. PMID: 18839161 Review.

4

[Genetic testing].

Azuma J, Nonen S. Azuma J, et al. Nihon Rinsho. 2007 Apr 28;65 Suppl 4:455-9. Nihon Rinsho. 2007. PMID: 17508579 Review. Japanese. No abstract available.

5

Adrenergic beta1 receptor polymorphism (Ser49Gly) is associated with obesity in type II diabetic patients.

Nonen S, Yamamoto I, Liu J, Maeda M, Motomura T, Igarashi T, Fujio Y, Azuma J. Nonen S, et al. Among authors: azuma j. Biol Pharm Bull. 2008 Feb;31(2):295-8. doi: 10.1248/bpb.31.295. Biol Pharm Bull. 2008. PMID: 18239290 Free article.

6

CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.

Kubota T, Nakajima-Taniguchi C, Fukuda T, Funamoto M, Maeda M, Tange E, Ueki R, Kawashima K, Hara H, Fujio Y, Azuma J. Kubota T, et al. Among authors: azuma j. Pharmacogenomics J. 2006 Mar-Apr;6(2):115-9. doi: 10.1038/sj.tpj.6500348. Pharmacogenomics J. 2006. PMID: 16402086

7

MTHFR gene polymorphism and diabetic retinopathy.

Maeda M, Fujio Y, Azuma J. Maeda M, et al. Among authors: azuma j. Curr Diabetes Rev. 2006 Nov;2(4):467-76. doi: 10.2174/1573399810602040467. Curr Diabetes Rev. 2006. PMID: 18220649 Review.

8

Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients.

Ohno M, Yamamoto A, Ono A, Miura G, Funamoto M, Takemoto Y, Otsu K, Kouno Y, Tanabe T, Masunaga Y, Nonen S, Fujio Y, Azuma J. Ohno M, et al. Among authors: azuma j. Eur J Clin Pharmacol. 2009 Nov;65(11):1097-103. doi: 10.1007/s00228-009-0685-9. Epub 2009 Jul 7. Eur J Clin Pharmacol. 2009. PMID: 19582440

9

Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy.

Yamada T, Nakayama M, Shimizu T, Nonen S, Nakai Y, Nishimura K, Fujio Y, Okuyama A, Azuma J, Nonomura N. Yamada T, et al. Among authors: azuma j. Int J Clin Oncol. 2013 Aug;18(4):711-7. doi: 10.1007/s10147-012-0430-8. Epub 2012 Jun 21. Int J Clin Oncol. 2013. PMID: 22714708

10

CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers.

Fukuda T, Onishi S, Fukuen S, Ikenaga Y, Ohno M, Hoshino K, Matsumoto K, Maihara A, Momiyama K, Ito T, Fujio Y, Azuma J. Fukuda T, et al. Among authors: azuma j. Pharmacogenomics J. 2004;4(1):34-9. doi: 10.1038/sj.tpj.6500218. Pharmacogenomics J. 2004. PMID: 14647405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters